Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeanne M Link

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
Biomedicines|May 25, 2017
Glioma FMISO PET/MR Imaging Concurrent with Antiangiogenic Therapy: Molecular Imaging as a Clinical Tool in the Burgeoning Era of Personalized MedicineRamon F Barajas, Kenneth A Krohn, Jeanne M Link, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2007
Tumor-specific positron emission tomography imaging in patients: [18F] fluorodeoxyglucose and beyondDavid A Mankoff, Janet F Eary, Jeanne M Link, et al.
Clinical Pharmacology and Therapeutics|June 18, 2005
Imaging P-glycoprotein transport activity at the human blood-brain barrier with positron emission tomographyLucy Sasongko, Jeanne M Link, Mark Muzi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 4, 2006
Kinetic analysis of 3'-deoxy-3'-18F-fluorothymidine in patients with gliomasMark Muzi, Alexander M Spence, Finbarr O'Sullivan, et al.
Molecular Imaging and Biology|March 28, 2009
NCI-sponsored trial for the evaluation of safety and preliminary efficacy of 3'-deoxy-3'-[18F]fluorothymidine (FLT) as a marker of proliferation in patients with recurrent gliomas: preliminary efficacy studiesAlexander M Spence, Mark Muzi, Jeanne M Link, et al.
Bioconjugate Chemistry|March 18, 2004
Production of [F-18]fluoroannexin for imaging apoptosis with PETJohn R Grierson, Kevin J Yagle, Janet F Eary, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 2009
Simultaneous PET imaging of P-glycoprotein inhibition in multiple tissues in the pregnant nonhuman primateSara Eyal, Francisco S Chung, Mark Muzi, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 7, 2016
Temporal Heterogeneity of Estrogen Receptor Expression in Bone-Dominant Breast Cancer: 18F-Fluoroestradiol PET Imaging Shows Return of ER ExpressionErin Currin, Lanell M Peterson, Erin K Schubert, et al.
Annals of Surgical Oncology|January 19, 2006
[11C]metahydroxyephedrine and [18F]fluorodeoxyglucose positron emission tomography improve clinical decision making in suspected pheochromocytomaGary N Mann, Jeanne M Link, Pam Pham, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 6, 2005
Evaluation of 18F-annexin V as a PET imaging agent in an animal model of apoptosisKevin J Yagle, Janet F Eary, Jonathan F Tait, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Biomedicines|May 25, 2017
Glioma FMISO PET/MR Imaging Concurrent with Antiangiogenic Therapy: Molecular Imaging as a Clinical Tool in the Burgeoning Era of Personalized MedicineRamon F Barajas, Kenneth A Krohn, Jeanne M Link, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2007
Tumor-specific positron emission tomography imaging in patients: [18F] fluorodeoxyglucose and beyondDavid A Mankoff, Janet F Eary, Jeanne M Link, et al.
Clinical Pharmacology and Therapeutics|June 18, 2005
Imaging P-glycoprotein transport activity at the human blood-brain barrier with positron emission tomographyLucy Sasongko, Jeanne M Link, Mark Muzi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 4, 2006
Kinetic analysis of 3'-deoxy-3'-18F-fluorothymidine in patients with gliomasMark Muzi, Alexander M Spence, Finbarr O'Sullivan, et al.
Molecular Imaging and Biology|March 28, 2009
NCI-sponsored trial for the evaluation of safety and preliminary efficacy of 3'-deoxy-3'-[18F]fluorothymidine (FLT) as a marker of proliferation in patients with recurrent gliomas: preliminary efficacy studiesAlexander M Spence, Mark Muzi, Jeanne M Link, et al.
Bioconjugate Chemistry|March 18, 2004
Production of [F-18]fluoroannexin for imaging apoptosis with PETJohn R Grierson, Kevin J Yagle, Janet F Eary, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 2009
Simultaneous PET imaging of P-glycoprotein inhibition in multiple tissues in the pregnant nonhuman primateSara Eyal, Francisco S Chung, Mark Muzi, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 7, 2016
Temporal Heterogeneity of Estrogen Receptor Expression in Bone-Dominant Breast Cancer: 18F-Fluoroestradiol PET Imaging Shows Return of ER ExpressionErin Currin, Lanell M Peterson, Erin K Schubert, et al.
Annals of Surgical Oncology|January 19, 2006
[11C]metahydroxyephedrine and [18F]fluorodeoxyglucose positron emission tomography improve clinical decision making in suspected pheochromocytomaGary N Mann, Jeanne M Link, Pam Pham, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 6, 2005
Evaluation of 18F-annexin V as a PET imaging agent in an animal model of apoptosisKevin J Yagle, Janet F Eary, Jonathan F Tait, et al.
Pageof 6